238 related articles for article (PubMed ID: 18765504)
1. The case-crossover study design in pharmacoepidemiology.
Delaney JA; Suissa S
Stat Methods Med Res; 2009 Feb; 18(1):53-65. PubMed ID: 18765504
[TBL] [Abstract][Full Text] [Related]
2. Drug drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding.
Delaney JA; Opatrny L; Brophy JM; Suissa S
CMAJ; 2007 Aug; 177(4):347-51. PubMed ID: 17698822
[TBL] [Abstract][Full Text] [Related]
3. Benzodiazepines and elderly drivers: a comparison of pharmacoepidemiological study designs.
Hebert C; Delaney JA; Hemmelgarn B; Lévesque LE; Suissa S
Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):845-9. PubMed ID: 17563091
[TBL] [Abstract][Full Text] [Related]
4. Control for seasonal variation and time trend in case-crossover studies of acute effects of environmental exposures.
Bateson TF; Schwartz J
Epidemiology; 1999 Sep; 10(5):539-44. PubMed ID: 10468428
[TBL] [Abstract][Full Text] [Related]
5. Exposure-time-varying hazard function ratios in case-control studies of drug effects.
Guess HA
Pharmacoepidemiol Drug Saf; 2006 Feb; 15(2):81-92. PubMed ID: 16287211
[TBL] [Abstract][Full Text] [Related]
6. Validating a method that deals with missing drug information in the Saskatchewan Drug Plan database.
Tamim HM; Tagalakis V
Pharmacoepidemiol Drug Saf; 2009 Feb; 18(2):140-6. PubMed ID: 19090502
[TBL] [Abstract][Full Text] [Related]
7. Supplementary data collection with case-cohort analysis to address potential confounding in a cohort study of thromboembolism in oral contraceptive initiators matched on claims-based propensity scores.
Eng PM; Seeger JD; Loughlin J; Clifford CR; Mentor S; Walker AM
Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):297-305. PubMed ID: 18215000
[TBL] [Abstract][Full Text] [Related]
8. Application of case-crossover and case-time-control study designs in analyses of time-varying predictors of T-cell homeostasis failure.
Schneider MF; Gange SJ; Margolick JB; Detels R; Chmiel JS; Rinaldo C; Armenian HK
Ann Epidemiol; 2005 Feb; 15(2):137-44. PubMed ID: 15652719
[TBL] [Abstract][Full Text] [Related]
9. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
10. [Contribution of case-crossover design to the analysis of short-term health effects of air pollution: reanalysis of air pollution and health data].
Chardon B; Host S; Pedrono G; Gremy I
Rev Epidemiol Sante Publique; 2008 Feb; 56(1):31-40. PubMed ID: 18262376
[TBL] [Abstract][Full Text] [Related]
11. Case-crossover and case-time-control designs as alternatives in pharmacoepidemiologic research.
Schneeweiss S; Stürmer T; Maclure M
Pharmacoepidemiol Drug Saf; 1997 Oct; 6 Suppl 3():S51-9. PubMed ID: 15073755
[TBL] [Abstract][Full Text] [Related]
12. Bidirectional case-crossover designs for exposures with time trends.
Navidi W
Biometrics; 1998 Jun; 54(2):596-605. PubMed ID: 9629646
[TBL] [Abstract][Full Text] [Related]
13. Use of the case-crossover design to study prolonged drug exposures and insidious outcomes.
Wang PS; Schneeweiss S; Glynn RJ; Mogun H; Avorn J
Ann Epidemiol; 2004 Apr; 14(4):296-303. PubMed ID: 15066610
[TBL] [Abstract][Full Text] [Related]
14. Estimation of time-dependent rate ratios in case-control studies: comparison of two approaches for exposure assessment.
Lefebvre G; Angers JF; Blais L
Pharmacoepidemiol Drug Saf; 2006 May; 15(5):304-16. PubMed ID: 16389656
[TBL] [Abstract][Full Text] [Related]
15. Application of lag-time into exposure definitions to control for protopathic bias.
Tamim H; Monfared AA; LeLorier J
Pharmacoepidemiol Drug Saf; 2007 Mar; 16(3):250-8. PubMed ID: 17245804
[TBL] [Abstract][Full Text] [Related]
16. The case-crossover and case-time-control designs in pharmacoepidemiology.
Donnan PT; Wang J
Pharmacoepidemiol Drug Saf; 2001 May; 10(3):259-62. PubMed ID: 11501340
[No Abstract] [Full Text] [Related]
17. A case-crossover analysis of a case-control study of alcohol consumption and coronary events: the effects of exposure definition and the use of control data.
Marshall RJ; Wouters S; Jackson RT
J Epidemiol Biostat; 2000; 5(6):367-73. PubMed ID: 11234741
[TBL] [Abstract][Full Text] [Related]
18. When should case-only designs be used for safety monitoring of medical products?
Maclure M; Fireman B; Nelson JC; Hua W; Shoaibi A; Paredes A; Madigan D
Pharmacoepidemiol Drug Saf; 2012 Jan; 21 Suppl 1():50-61. PubMed ID: 22262593
[TBL] [Abstract][Full Text] [Related]
19. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
[TBL] [Abstract][Full Text] [Related]
20. Confounding in database pharmacoepidemiology studies.
Delaney JA; Opatrny L; Brophy JM; Suissa S
Epidemiology; 2008 Mar; 19(2):360-1. PubMed ID: 18277175
[No Abstract] [Full Text] [Related]
[Next] [New Search]
